Page last updated: 2024-10-21

menthol and Genetic Predisposition

menthol has been researched along with Genetic Predisposition in 2 studies

Menthol: A monoterpene cyclohexanol produced from mint oils.

Research Excerpts

ExcerptRelevanceReference
"Novel pharmacotherapies for nicotine dependence include partial agonists for nicotinic receptors and nicotine vaccines."2.44Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. ( Benowitz, NL, 2008)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Park, SJ1
Yi, B1
Lee, HS1
Oh, WY1
Na, HK1
Lee, M1
Yang, M1
Benowitz, NL1

Clinical Trials (4)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Developing Genetic Education for Smoking Cessation[NCT01186016]103 participants (Actual)Interventional2010-02-01Completed
The Appeal and Impact of E-cigarettes in Smokers With Serious Mental Illness[NCT03050853]240 participants (Actual)Interventional2017-03-01Completed
Tobacco Treatment Outreach to Reduce Disparities for Primary Care Populations[NCT01156610]706 participants (Actual)Interventional2011-11-30Completed
Smokers' Response to Nicotine Dependence Genotyping[NCT01780038]24 participants (Actual)Interventional2012-11-14Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Knowledge of Genetic Contributions to Smoking

Knowledge of genetic contributions to smoking. Name of Scale: Genetic Knowledge Test (9 items). Minimum/Maximum Scores: 0-9. Higher score means better outcome. (NCT01186016)
Timeframe: One week after completion of the two Educational Sessions (GES or NES). Educational sessions occurred over two weeks.

,
Interventionscore on a scale (Mean)
BaselineEnd of Educational Sessions
Genetic Education Session (GES)5.257.04
Nutrition Education Session (NES)3.734.03

Smoking-Related Appraisals

Self-efficacy for Quitting/Resisting Smoking. Self-efficacy/Temptation Scale (Velicer, DiClemente, Rossi & Prochaska, 1990) Total Score. Scores range from 1 to 5, with higher scores indicating greater self-efficacy. Source: Velicer, W.F., DiClemente, C.C., Rossi, J.S., & Prochaska, J.O. (1990). Relapse situations and self-efficacy: An integrative model. Addictive Behaviors, 15, 271-283. (NCT01186016)
Timeframe: Six weeks after the baseline data collection, which was the end of the Smoking Cession Sessions.

,
Interventionscore on a scale (Mean)
BaselineEnd of Educational SessionsEnd of Smoking Cessation Sessions
Genetic Education Session (GES)3.933.802.73
Nutrition Education Session (NES)3.993.862.57

Reviews

2 reviews available for menthol and Genetic Predisposition

ArticleYear
To quit or not: Vulnerability of women to smoking tobacco.
    Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews, 2016, Volume: 34, Issue:1

    Topics: Behavior, Addictive; Epigenesis, Genetic; Female; Genetic Predisposition to Disease; Hormones; Human

2016
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
    Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:4

    Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American

2008
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
    Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:4

    Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American

2008
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
    Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:4

    Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American

2008
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
    Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:4

    Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American

2008
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
    Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:4

    Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American

2008
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
    Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:4

    Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American

2008
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
    Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:4

    Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American

2008
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
    Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:4

    Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American

2008
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
    Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:4

    Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American

2008
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
    Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:4

    Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American

2008
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
    Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:4

    Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American

2008
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
    Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:4

    Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American

2008
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
    Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:4

    Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American

2008
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
    Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:4

    Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American

2008
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
    Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:4

    Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American

2008
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
    Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:4

    Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American

2008